1Siegel R,Ma J,Zou Z,et al. Cancer statistics,2014[ J]. CA Cancer J Clin ,2014,64 ( 1 ) :9 - 29.
2Dauplat J, Le Bouedec G, Pomel C, et al. Cytoreductive surgery for ad- vanced stages of ovarian cancer[ J ]. Semin Surg Oncol,2000,19 (1) : 42 - 48.
3Mcguire WP, Hoskins WJ, Brady MF, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer[ J ]. N Engl J Mcd, 1996,334 (1) : 1-6.
4Lawton FG, Redman CW, Luesley DM, et al. Neoadjuvant ( cytoreduc- rive) chemotherapy combined with intervention debulking surgery in advanced, unresected epithelial ovarian cancer [ J ]. Obstet Gynecol, 1989,73 ( 1 ) :61 - 65.
5Morice P, Dubemard G, Rey A, et al. Results of interval debulkiug surgery compared with primary debulking surgery in advanced stage o- varian cancer [ J ]. J Am Coil Surg,2003,197 (6) :955 - 963.
6Everett EN, French AE,Stone RL, et al. Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III/IV epithelial o- varian cancer[ J ]. Am J Obstet Gynecol,2006,195 (2) :568 -574.
7Steed H, Oza AM, Murphy J, eta!. A retrospective analysis of neoadju- vant platinum-based chemotherapy versus up-front surgery in ad- vanced ovarian cancer [ J ]. Int J Gynecol Cancer,2006,16 ( Suppl 1 ) : 47 -53.
8Hou JY, Kelly MG, Yu H, et al. Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage 1V disease [ J]. Gynecol Oncol, 2007, 105 ( 1 ) : 211 -217.
9Bristow RE, Chi DS. Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a rec- ta-analysis[ J]. G~,necol Onco1,2006,103 (3) : 1070 - 1076.
10Kang S, Nam BH. Does neoadjuvant chemotherapy increase optimal cytoreduction rate in advanced ovarian cancer.'? Meta-analysis of 21 studies [ J ]. Ann Surg Onco1,2009,16 (8) :2315 - 2320.
10Huang XE,Wei GL. Intrapleural or intraperitoneal lobaplatin for treatment of patients with malignant pleural effusion or ascites [J].Asian Pac J Cancer Prev,2013,14(4):2611-2614.
